Practical Dermatology: Focus on Psoriasis
From the latest drug approvals to research on comorbidities and more, Focus On Psoriasis has the critical information you need from the team at Practical Dermatology.
PsO, PsA, and HS: Dr. Gottlieb
Practical Dermatology: Focus on PsoriasisPsO, PsA, and HS: Dr. Gottlieb
Verrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
Practical Dermatology: Focus on PsoriasisVerrucous Psoriasis: A Rare Variant Refractory to Topical Steroids
The Importance of Early Intervention for Psoriatic Arthritis
Practical Dermatology: Focus on PsoriasisThe Importance of Early Intervention for Psoriatic Arthritis
IFPA World PsO and PsA Conference
Practical Dermatology: Focus on PsoriasisIFPA World PsO and PsA Conference
In The Pipeline: Phase 1, 2, and 3
Practical Dermatology: Focus on PsoriasisIn The Pipeline: Phase 1, 2, and 3
The Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
Practical Dermatology: Focus on PsoriasisThe Latest on Systemic Agents for Psoriasis: A Q&A With Jashin J. Wu, MD, FAAD
"Psleep": Psoriasis and Sleep
Practical Dermatology: Focus on Psoriasis"Psleep": Psoriasis and Sleep
Annual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
Practical Dermatology: Focus on PsoriasisAnnual Trends in Medicare Part D Prescription Claims for Guselkumab, 2018–2020
Noah Worcester 2024: Dr. Glick on Systemic Therapies for Psoriasis
Practical Dermatology: Focus on PsoriasisNoah Worcester 2024: Dr. Glick on Systemic Therapies for Psoriasis
Turmeric Tonic as a Treatment in Scalp Psoriasis
Practical Dermatology: Focus on PsoriasisTurmeric Tonic as a Treatment in Scalp Psoriasis
New Drugs & Therapies 2024 Recap
Practical Dermatology: Focus on PsoriasisNew Drugs & Therapies 2024 Recap
- 03/06/2025